164 related articles for article (PubMed ID: 37777699)
1. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes.
He J; Yang M; Song C; Zhang R; Yuan S; Li J; Dou K
J Endocrinol Invest; 2024 Apr; 47(4):883-894. PubMed ID: 37777699
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.
Jin JL; Cao YX; Zhang HW; Sun D; Hua Q; Li YF; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu HH; Dong Q; Li JJ
Diabetes Care; 2019 Jul; 42(7):1312-1318. PubMed ID: 31076417
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein (a) predicts recurrent worse outcomes in type 2 diabetes mellitus patients with prior cardiovascular events: a prospective, observational cohort study.
Zhang Y; Jin JL; Cao YX; Zhang HW; Guo YL; Wu NQ; Zhu CG; Gao Y; Hua Q; Li YF; Xu RX; Li JJ
Cardiovasc Diabetol; 2020 Jul; 19(1):111. PubMed ID: 32646432
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a), hypertension, and cardiovascular outcomes: a prospective study of patients with stable coronary artery disease.
Liu HH; Cao YX; Jin JL; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Dong Q; Li JJ
Hypertens Res; 2021 Sep; 44(9):1158-1167. PubMed ID: 34035483
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
[TBL] [Abstract][Full Text] [Related]
6. Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study.
Jin JL; Cao YX; Wu LG; You XD; Guo N; Guo YL; Wu NQ; Zhu CG; Xu RX; Liu HH; Sun J; Dong Q; Gao Y; Li JJ
BMJ Open; 2021 Jan; 11(1):e037340. PubMed ID: 33455923
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study.
Zhang Y; Jin JL; Cao YX; Liu HH; Zhang HW; Guo YL; Wu NQ; Gao Y; Hua Q; Li YF; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
J Transl Med; 2020 Oct; 18(1):373. PubMed ID: 33004038
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study.
Zhang HW; Jin JL; Cao YX; Liu HH; Zhang Y; Guo YL; Wu NQ; Gao Y; Xu RX; Hua Q; Li YF; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
Cardiovasc Diabetol; 2020 Feb; 19(1):15. PubMed ID: 32041617
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients.
Kwon SW; Lee BK; Hong BK; Kim JY; Choi EY; Sung JM; Rhee JH; Park YM; Ma DW; Chung H; Mun HS; Lee SJ; Park JK; Min PK; Yoon YW; Rim SJ; Kwon HM
Int J Cardiol; 2013 Sep; 167(5):1990-4. PubMed ID: 22633779
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
[TBL] [Abstract][Full Text] [Related]
12. Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.
Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Santos R; Li JJ
Cardiovasc Diabetol; 2020 Sep; 19(1):152. PubMed ID: 32981521
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes.
Jin JL; Zhang HW; Liu HH; Zhu CG; Guo YL; Wu NQ; Xu RX; Dong Q; Li JJ
Front Cardiovasc Med; 2022; 9():870341. PubMed ID: 35669468
[TBL] [Abstract][Full Text] [Related]
14. Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease.
Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Hong LF; Li JJ
Heart; 2020 Aug; 106(16):1228-1235. PubMed ID: 32381650
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impacts of diabetes status and lipoprotein(a) levels in patients with ST-segment elevation myocardial infarction: a prospective cohort study.
Li N; Zhou J; Chen R; Zhao X; Li J; Zhou P; Liu C; Chen Y; Wang Y; Song L; Yan S; Zhao H; Yan H
Cardiovasc Diabetol; 2023 Jun; 22(1):151. PubMed ID: 37365608
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) predicts recurrent cardiovascular events in patients with prior cardiovascular events post-PCI: five-year findings from a large single center cohort study.
Xu N; Yao Y; Jiang L; Xu J; Wang H; Song Y; Yang Y; Xu B; Gao R; Yuan J
Thromb J; 2022 Nov; 20(1):69. PubMed ID: 36414932
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: A Prospective Cohort Study.
Cao YX; Zhang HW; Jin JL; Liu HH; Zhang Y; Zhang M; Gao Y; Guo YL; Wu NQ; Zhu CG; Dong Q; Sun J; Wang LF; Gao RL; Li JJ
Thromb Haemost; 2021 Sep; 121(9):1161-1168. PubMed ID: 33339063
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.
Naka KK; Bechlioullis A; Marini A; Sionis D; Vakalis K; Triantis G; Wilkins L; Rogus J; Kornman KS; Witztum JL; Doucette-Stamm L; Michalis LK; Tsimikas S
J Clin Lipidol; 2018; 12(2):338-347. PubMed ID: 29310992
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic Fatty Liver Disease Is Associated With Cardiovascular Outcomes in Subjects With Prediabetes and Diabetes: A Prospective Community-Based Cohort Study.
Song QR; Liu SL; Bi YG; Chen SH; Wu SL; Cai J
Front Cardiovasc Med; 2022; 9():889597. PubMed ID: 35557545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
